Cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total
IDA & IBRD total: Cause of death, by non-communicable diseases, ages 15-59, male was 48.6% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total stood at 48.6%. That is the lowest value across all 6 years on record.
The figure is down 12.0% on the previous year and down 10.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total peaked at 59.6% in 2019 and was at its lowest, 48.6%, in 2021.
IDA & IBRD total ranks 22nd of 47 groups on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total, year by year
| Year | % of total male deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 48.8% | — |
| 2010 | 54.4% | +11.3% |
| 2015 | 57.1% | +4.9% |
| 2019 | 59.6% | +4.4% |
| 2020 | 55.3% | -7.2% |
| 2021 | 48.6% | -12.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.8% | 48.8% | 48.8% | 1 |
| 2010s | 57.0% | 54.4% | 59.6% | 3 |
| 2020s | 51.9% | 48.6% | 55.3% | 2 |
Countries ranked near IDA & IBRD total
- 19 Estonia 73.3% compare
- 20 Luxembourg 72.5% compare
- 21 Japan 72.4% compare
- 22 Australia 72.4% compare
- 23 Micronesia (country) 72.3% compare
- 24 Cyprus 72.2% compare
- 25 Switzerland 72.2% compare
More health data for IDA & IBRD total
- Population ages 35-39, female, annual growth rate 1.62 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0326 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 2.26 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0375 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.81 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0362 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, per capita 0.0384 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total?
- Cause of death, by non-communicable diseases, ages 15-59, male in IDA & IBRD total was 48.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, male recorded in IDA & IBRD total?
- The highest recorded value was 59.6% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, male recorded in IDA & IBRD total?
- The lowest recorded value was 48.6% in 2021.
- How does IDA & IBRD total rank for cause of death, by non-communicable diseases, ages 15-59, male?
- IDA & IBRD total ranks 22nd out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, male rising or falling in IDA & IBRD total?
- Over the last ten years it is down 10.6%. The long-run trend across the full record is rising.
- Where does this IDA & IBRD total data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.